Weight Loss · Lisle, IL

Tirzepatide for Weight Loss in Lisle, IL

Medically supervised tirzepatide protocols, prescribed and monitored by our clinical team. Custom dosing, weekly check-ins, real accountability.

Book a Free Consultation

What Is Tirzepatide?

Tirzepatide is a dual GIP and GLP-1 receptor agonist FDA-approved for chronic weight management (under the brand name Zepbound) and type 2 diabetes (Mounjaro). Developed by Eli Lilly, it is administered as a once-weekly subcutaneous injection.

Generic name	Tirzepatide
Brand names	Zepbound (weight loss), Mounjaro (type 2 diabetes)
Manufacturer	Eli Lilly
FDA approval (weight loss)	November 2023
Mechanism	Dual GIP / GLP-1 receptor agonist
Administration	Once-weekly subcutaneous injection
Typical dose range	2.5 mg to 15 mg (titrated over months)

The Science

How Tirzepatide Works

Dual hormone activation

Tirzepatide activates two hormone receptors involved in appetite and blood sugar regulation: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1).

Reduced appetite

The combined GIP/GLP-1 signal acts on the brain to reduce hunger and food cravings. Most patients report eating significantly less without consciously trying.

Slower gastric emptying

Tirzepatide slows the rate at which the stomach empties, which increases the feeling of fullness after meals and helps stabilize blood sugar between meals.

Improved insulin sensitivity

By activating both incretin pathways, tirzepatide improves how the body responds to insulin. This is part of why it produces stronger metabolic results than GLP-1-only medications.

Clinical Research

What Research Shows About Tirzepatide

In the SURMOUNT-1 trial (published in the New England Journal of Medicine, 2022), adults with obesity who took 15 mg tirzepatide weekly lost an average of 22.5% of their body weight over 72 weeks. The 10 mg dose produced an average of 21.4%, and the 5 mg dose produced 16.0%.

For comparison, the highest semaglutide dose (2.4 mg, Wegovy) produced an average weight loss of approximately 15% in the STEP-1 trial. Tirzepatide also showed improvements in blood pressure, cholesterol, blood glucose, and waist circumference in trial participants.

Follow-up data from the SURMOUNT-4 trial suggested that continued tirzepatide treatment is needed to maintain weight loss; patients who discontinued treatment regained a significant portion of lost weight over 12 months.

Side-by-Side

Tirzepatide vs Semaglutide

Tirzepatide and semaglutide are the two most prescribed GLP-1 weight loss medications. Both are once-weekly injections, but their mechanisms and efficacy differ.

	Tirzepatide	Semaglutide
Mechanism	Dual GIP / GLP-1 agonist	GLP-1 agonist only
Average weight loss (highest dose)	~22.5%	~15%
FDA approval (weight loss)	2023 (Zepbound)	2021 (Wegovy)
Brand names	Zepbound, Mounjaro	Wegovy, Ozempic, Rybelsus
Manufacturer	Eli Lilly	Novo Nordisk
Administration	Weekly injection	Weekly injection

Learn about semaglutide →

Our Program

Tirzepatide at Defiant Health

Free Consultation

Meet with our medical team to discuss your goals, medical history, and whether tirzepatide is right for you. No commitment.

Bloodwork & Body Scan

Comprehensive bloodwork to confirm eligibility, plus a 3D body composition scan to establish your starting baseline.

Custom Protocol

Personalized tirzepatide dosing and titration schedule built around your labs, body composition, and goals.

Ongoing Support

Weekly nurse check-ins, monthly body composition scans, and real-time dose adjustments as you progress.

Pricing

Custom GLP-1 Protocols from $295/mo

Includes medication, provider oversight, weekly nurse check-ins, and monthly body composition scans. Defiant members save 20%.

Book Your Consultation

Good Candidates

Who Tirzepatide Is For

+ Adults with a BMI of 30 or higher
+ Adults with a BMI of 27 or higher with at least one weight-related condition (high blood pressure, type 2 diabetes, sleep apnea, cardiovascular disease)
+ People who have tried lifestyle changes without sustained results
+ People who are committed to lifestyle support alongside medication

Contraindications

Who Tirzepatide Is Not For

− Pregnant or breastfeeding individuals
− Personal or family history of medullary thyroid carcinoma
− Multiple endocrine neoplasia syndrome type 2 (MEN-2)
− Severe gastrointestinal disease, including gastroparesis
− Active pancreatitis or history of pancreatitis

Our medical team reviews your full history before prescribing. This is not an exhaustive list of contraindications.

FAQ

Tirzepatide Questions

Plain-language answers to the most common questions about tirzepatide treatment at Defiant in Lisle, IL.

Tirzepatide is a prescription medication FDA-approved for chronic weight management and type 2 diabetes. It is sold under the brand names Zepbound (for weight loss) and Mounjaro (for diabetes), both made by Eli Lilly. Tirzepatide is a dual GIP and GLP-1 receptor agonist, administered as a once-weekly subcutaneous injection.

The main difference is mechanism. Semaglutide (Wegovy, Ozempic) activates only the GLP-1 receptor. Tirzepatide activates both the GLP-1 and GIP receptors. In head-to-head clinical research, tirzepatide has produced greater average weight loss (22.5% at the highest dose) than semaglutide (about 15% at its highest dose).

In the SURMOUNT-1 trial, participants on the highest dose (15 mg weekly) lost an average of 22.5% of their body weight over 72 weeks. Individual results vary based on dose, duration, lifestyle factors, and adherence. Most people see meaningful weight loss within the first 12 weeks of treatment.

The most common side effects are gastrointestinal: nausea, diarrhea, constipation, vomiting, and reduced appetite. These are usually mild to moderate and most common during dose escalation. Serious but rare side effects include pancreatitis, gallbladder issues, and severe gastrointestinal events. Tirzepatide carries a boxed warning for thyroid C-cell tumors.

Most patients see meaningful appetite suppression within the first 1 to 2 weeks. Visible weight loss typically begins within the first month. Significant weight loss typically takes 3 to 6 months of consistent use, with continued progress over 12 to 18 months in clinical trials.

Yes. Tirzepatide is a prescription-only medication. At Defiant Health, our medical team evaluates whether tirzepatide is appropriate for you based on bloodwork, body composition, medical history, and goals.

Our Custom GLP-1 Protocols, including tirzepatide, start at $295 per month. Defiant members save 20%. Pricing includes the medication, provider oversight, weekly nurse check-ins, and monthly body composition scans.

Research from the SURMOUNT-4 trial suggests that most people regain a significant portion of lost weight after stopping tirzepatide. For long-term weight management, ongoing treatment combined with lifestyle support is typically required. Our team can discuss long-term protocol strategies during your consultation.

Defiant Health offers tirzepatide weight loss programs at our clinic in Lisle, IL, serving Naperville, Downers Grove, Wheaton, Bolingbrook, Lombard, and the greater Chicago western suburbs. Book a free consultation to determine if tirzepatide is right for you.

Get Started

Tirzepatide Weight Loss in Chicago’s Western Suburbs

Defiant Health offers tirzepatide weight loss programs at our Lisle, IL clinic — serving Naperville, Downers Grove, Wheaton, Bolingbrook, Lombard, and the greater Chicago western suburbs.

Book a Free Consultation

References

1. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205-216. View source →
2. U.S. Food and Drug Administration. FDA approves new medication for chronic weight management. November 8, 2023. View source →
3. Aronne LJ, Sattar N, Horn DB, et al. Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: The SURMOUNT-4 randomized clinical trial. JAMA. 2024;331(1):38-48. View source →

This page is for educational purposes only and does not constitute medical advice. Tirzepatide is a prescription medication. Consult a licensed healthcare provider for advice specific to your situation. Defiant Health does not bill insurance directly.